{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T22:47:25Z","timestamp":1793573245977,"version":"4.5.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T00:00:00Z","timestamp":1746576000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T00:00:00Z","timestamp":1746576000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"This research project received financial support from the UNICEF\/UNDP\/World Bank\/WHO Special Programme for Research and Training in Tropical Diseases","award":["PO202606230"],"award-info":[{"award-number":["PO202606230"]}]},{"name":"This research project received financial support from the UNICEF\/UNDP\/World Bank\/WHO Special Programme for Research and Training in Tropical Diseases","award":["PO202606230"],"award-info":[{"award-number":["PO202606230"]}]},{"name":"This research project received financial support from the UNICEF\/UNDP\/World Bank\/WHO Special Programme for Research and Training in Tropical Diseases","award":["PO202606230"],"award-info":[{"award-number":["PO202606230"]}]},{"name":"This research project received financial support from the UNICEF\/UNDP\/World Bank\/WHO Special Programme for Research and Training in Tropical Diseases","award":["PO202606230"],"award-info":[{"award-number":["PO202606230"]}]},{"name":"This research project received financial support from the UNICEF\/UNDP\/World Bank\/WHO Special Programme for Research and Training in Tropical Diseases","award":["PO202606230"],"award-info":[{"award-number":["PO202606230"]}]},{"name":"This research project received financial support from the UNICEF\/UNDP\/World Bank\/WHO Special Programme for Research and Training in Tropical Diseases","award":["PO202606230"],"award-info":[{"award-number":["PO202606230"]}]},{"name":"This research project received financial support from the UNICEF\/UNDP\/World Bank\/WHO Special Programme for Research and Training in Tropical Diseases","award":["PO202606230"],"award-info":[{"award-number":["PO202606230"]}]},{"name":"This research project received financial support from the UNICEF\/UNDP\/World Bank\/WHO Special Programme for Research and Training in Tropical Diseases","award":["PO202606230"],"award-info":[{"award-number":["PO202606230"]}]},{"name":"This research project received financial support from the UNICEF\/UNDP\/World Bank\/WHO Special Programme for Research and Training in Tropical Diseases","award":["PO202606230"],"award-info":[{"award-number":["PO202606230"]}]},{"name":"This research project received financial support from the UNICEF\/UNDP\/World Bank\/WHO Special Programme for Research and Training in Tropical Diseases","award":["PO202606230"],"award-info":[{"award-number":["PO202606230"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-11068-1","type":"journal-article","created":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T12:55:24Z","timestamp":1746622524000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Non-inferiority stepped wedge cluster randomized controlled trial on all-oral shorter regimens for rifampicin resistant\/multidrug-resistant TB in Pakistan \u2013 a study protocol"],"prefix":"10.1186","volume":"25","author":[{"given":"Nida","family":"Khan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Ahmar","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naila","family":"Muzaffar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul","family":"Ghafoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathon R.","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwenaelle","family":"Le Coroller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zia Un","family":"Nisa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne Simone","family":"Merle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Amir","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,7]]},"reference":[{"key":"11068_CR1","doi-asserted-by":"crossref","unstructured":"Matteelli A, Rendon A, Tiberi S, Al-Abri S, Voniatis C, Carvalho AC, Centis R, D\u2019Ambrosio L, Visca D, Spanevello A, Migliori GB. Tuberculosis elimination: where are we now?. European Respiratory Review. 2018;27(148).","DOI":"10.1183\/16000617.0035-2018"},{"key":"11068_CR2","unstructured":"World Health Organization. WHO consolidated guidelines on drug-resistant tuberculosis treatment. World Health Organization; 2019."},{"issue":"6","key":"11068_CR3","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1111\/jam.14478","volume":"128","author":"R Singh","year":"2020","unstructured":"Singh R, Dwivedi SP, Gaharwar US, Meena R, Rajamani P, Prasad T. Recent updates on drug resistance in Mycobacterium tuberculosis. J Appl Microbiol. 2020;128(6):1547\u201367.","journal-title":"J Appl Microbiol"},{"issue":"1","key":"11068_CR4","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1186\/s12879-024-09079-5","volume":"24","author":"H Lv","year":"2024","unstructured":"Lv H, Zhang X, Zhang X, Bai J, You S, Li X, Li S, Wang Y, Zhang W, Xu Y. Global prevalence and burden of multidrug-resistant tuberculosis from 1990 to 2019. BMC Infect Dis. 2024;24(1):243.","journal-title":"BMC Infect Dis"},{"issue":"2","key":"11068_CR5","doi-asserted-by":"publisher","first-page":"133","DOI":"10.33073\/pjm-2020-005","volume":"69","author":"S Ali","year":"2020","unstructured":"Ali S, Khan MT, Khan AS, Mohammad N, Khan MM, Ahmad S, Noor S, Jabbar A, Daire C, Hassan F. Prevalence of multi-drug resistant Mycobacterium tuberculosis in Khyber Pakhtunkhwa\u2013a high tuberculosis endemic area of Pakistan. Pol J Microbiol. 2020;69(2):133\u20137.","journal-title":"Pol J Microbiol"},{"issue":"2","key":"11068_CR6","doi-asserted-by":"publisher","first-page":"100042","DOI":"10.1016\/j.ssmqr.2022.100042","volume":"1","author":"HA Taylor","year":"2022","unstructured":"Taylor HA, Dowdy DW, Searle AR, Stennett AL, Dukhanin V, Zwerling AA, Merritt MW. Disadvantage and the experience of treatment for multidrug-resistant tuberculosis (MDR-TB). SSM-Qualitative Res Health. 2022;1(2):100042.","journal-title":"SSM-Qualitative Res Health"},{"issue":"1","key":"11068_CR7","doi-asserted-by":"publisher","first-page":"54","DOI":"10.5588\/ijtld.23.0272","volume":"28","author":"D Surie","year":"2024","unstructured":"Surie D, Sathyanarayanan MK, Lavanya J, Smith JP, Shanmugam SK, Tamilzhalagan S, Selvaraj A, Ramesh G, Tripathy S, Khaparde SD, Ho CS. Long-term follow-up of persons diagnosed with multidrug-resistant TB in Chennai, India, 2013\u20132020. Int J Tuberc Lung Dis. 2024;28(1):54.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"10","key":"11068_CR8","doi-asserted-by":"publisher","first-page":"e384","DOI":"10.1371\/journal.pmed.0030384","volume":"3","author":"H Cox","year":"2006","unstructured":"Cox H, Kebede Y, Allamuratova S, Ismailov G, Davletmuratova Z, Byrnes G, Stone C, Niemann S, R\u00fcsch-Gerdes S, Blok L, Doshetov D. Tuberculosis recurrence and mortality after successful treatment: impact of drug resistance. PLoS Med. 2006;3(10):e384.","journal-title":"PLoS Med"},{"issue":"6","key":"11068_CR9","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1093\/cid\/ciae145","volume":"78","author":"H Morgan","year":"2024","unstructured":"Morgan H, Ndjeka N, Hasan T, Gegia M, Mirzayev F, Nguyen LN, Schumacher S, Schlub TE, Naidoo K, Fox GJ. Treatment of multidrug-resistant or rifampicin-resistant tuberculosis with an all-oral 9-month regimen containing linezolid or ethionamide in South Africa: A retrospective cohort study. Clin Infect Dis. 2024;78(6):1698\u2013706.","journal-title":"Clin Infect Dis"},{"issue":"10366","key":"11068_CR10","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1016\/S0140-6736(22)02078-5","volume":"400","author":"RL Goodall","year":"2022","unstructured":"Goodall RL, Meredith SK, Nunn AJ, Bayissa A, Bhatnagar AK, Bronson G, Chiang CY, Conradie F, Gurumurthy M, Kirenga B, Kiria N. Evaluation of two short standardised regimens for the treatment of rifampicin-resistant tuberculosis (STREAM stage 2): an open-label, multicentre, randomised, non-inferiority trial. Lancet. 2022;400(10366):1858\u201368.","journal-title":"Lancet"},{"issue":"10","key":"11068_CR11","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1164\/rccm.202107-1779OC","volume":"205","author":"A Esmail","year":"2022","unstructured":"Esmail A, Oelofse S, Lombard C, Perumal R, Mbuthini L, Goolam Mahomed A, Variava E, Black J, Oluboyo P, Gwentshu N, Ngam E. An all-oral 6-month regimen for multidrug-resistant tuberculosis: a multicenter, randomized controlled clinical trial (the NExT study). Am J Respir Crit Care Med. 2022;205(10):1214\u201327.","journal-title":"Am J Respir Crit Care Med"},{"key":"11068_CR12","unstructured":"World Health Organization. WHO operational handbook on tuberculosis: module 4: treatment: drug-resistant tuberculosis treatment. World Health Organization; 2020."},{"issue":"79","key":"11068_CR13","first-page":"104009","volume":"1","author":"MA Khan","year":"2022","unstructured":"Khan MA, Bilal W, Asim H, Rahmat ZS, Essar MY, Ahmad S. MDR-TB in Pakistan: Challenges, efforts, and recommendations. Annals of Medicine and Surgery. 2022;1(79):104009.","journal-title":"Annals of Medicine and Surgery"},{"key":"11068_CR14","doi-asserted-by":"crossref","unstructured":"Moher D, Chan AW. SPIRIT (standard protocol items: recommendations for interventional trials). Guidelines for Reporting Health Research: a user's manual. 2014:56-67.","DOI":"10.1002\/9781118715598.ch7"},{"key":"11068_CR15","unstructured":"World Health Organization. WHO consolidated guidelines on tuberculosis: module 4: treatment: drug-resistant tuberculosis treatment: online annexes. World Health Organization; 2020."},{"issue":"8","key":"11068_CR16","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1093\/aje\/kwr183","volume":"174","author":"LN Yelland","year":"2011","unstructured":"Yelland LN, Salter AB, Ryan P. Performance of the modified Poisson regression approach for estimating relative risks from clustered prospective data. Am J Epidemiol. 2011;174(8):984\u201392.","journal-title":"Am J Epidemiol"},{"issue":"2","key":"11068_CR17","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.cct.2006.05.007","volume":"28","author":"MA Hussey","year":"2007","unstructured":"Hussey MA, Hughes JP. Design and analysis of stepped wedge cluster randomized trials. Contemp Clin Trials. 2007;28(2):182\u201391.","journal-title":"Contemp Clin Trials"},{"issue":"2","key":"11068_CR18","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1177\/0962280220958735","volume":"30","author":"JA Thompson","year":"2021","unstructured":"Thompson JA, Hemming K, Forbes A, Fielding K, Hayes R. Comparison of small-sample standard-error corrections for generalised estimating equations in stepped wedge cluster randomised trials with a binary outcome: a simulation study. Stat Methods Med Res. 2021;30(2):425\u201339.","journal-title":"Stat Methods Med Res"},{"issue":"1","key":"11068_CR19","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1093\/jssam\/smz048","volume":"9","author":"PM Westgate","year":"2021","unstructured":"Westgate PM, West BT. Tools for selecting working correlation structures when using weighted GEE to model longitudinal survey data. J Surv Stat Methodol. 2021;9(1):141\u201358.","journal-title":"J Surv Stat Methodol"},{"issue":"11","key":"11068_CR20","first-page":"673","volume":"10","author":"MY Bertram","year":"2021","unstructured":"Bertram MY, Lauer JA, Stenberg K, Edejer TT. Methods for the economic evaluation of health care interventions for priority setting in the health system: an update from WHO CHOICE. Int J Health Policy Manag. 2021;10(11):673.","journal-title":"Int J Health Policy Manag"},{"issue":"3","key":"11068_CR21","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/0168-8510(90)90421-9","volume":"16","author":"Group TE","year":"1990","unstructured":"Group TE. EuroQol-a new facility for the measurement of health-related quality of life. Health Policy. 1990;16(3):199\u2013208.","journal-title":"Health Policy"},{"issue":"8","key":"11068_CR22","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1002\/hec.1608","volume":"19","author":"NJ Devlin","year":"2010","unstructured":"Devlin NJ, Parkin D, Browne J. Patient-reported outcome measures in the NHS: new methods for analysing and reporting EQ-5D data. Health Econ. 2010;19(8):886\u2013905.","journal-title":"Health Econ"},{"key":"11068_CR23","unstructured":"Shrestha B, Dunn L. The declaration of Helsinki on medical research involving human subjects: a review of seventh revision."},{"key":"11068_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2288-6-54","volume":"6","author":"CA Brown","year":"2006","unstructured":"Brown CA, Lilford RJ. The stepped wedge trial design: a systematic review. BMC Med Res Methodol. 2006;6:1\u20139.","journal-title":"BMC Med Res Methodol"},{"issue":"4","key":"11068_CR25","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.jclinepi.2013.10.018","volume":"67","author":"Z Zhan","year":"2014","unstructured":"Zhan Z, van den Heuvel ER, Doornbos PM, Burger H, Verberne CJ, Wiggers T, de Bock GH. Strengths and weaknesses of a stepped wedge cluster randomized design: its application in a colorectal cancer follow-up study. J Clin Epidemiol. 2014;67(4):454\u201361.","journal-title":"J Clin Epidemiol"},{"key":"11068_CR26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12874-015-0090-2","volume":"15","author":"E de Hoop","year":"2015","unstructured":"de Hoop E, van der Tweel I, van der Graaf R, Moons KG, van Delden JJ, Reitsma JB, Koffijberg H. The need to balance merits and limitations from different disciplines when considering the stepped wedge cluster randomized trial design. BMC Med Res Methodol. 2015;15:1\u20133.","journal-title":"BMC Med Res Methodol"},{"issue":"9","key":"11068_CR27","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1016\/j.jclinepi.2010.12.003","volume":"64","author":"ND Mdege","year":"2011","unstructured":"Mdege ND, Man MS, Taylor CA, Torgerson DJ. Systematic review of stepped wedge cluster randomized trials shows that design is particularly used to evaluate interventions during routine implementation. J Clin Epidemiol. 2011;64(9):936\u201348.","journal-title":"J Clin Epidemiol"},{"issue":"113","key":"11068_CR28","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1016\/j.ijid.2021.02.107","volume":"1","author":"J Chakaya","year":"2021","unstructured":"Chakaya J, Khan M, Ntoumi F, Aklillu E, Fatima R, Mwaba P, Kapata N, Mfinanga S, Hasnain SE, Katoto PD, Bulabula AN. Global Tuberculosis Report 2020\u2013Reflections on the Global TB burden, treatment and prevention efforts. Int J Infect Dis. 2021;1(113):S7-12.","journal-title":"Int J Infect Dis"},{"issue":"8","key":"11068_CR29","doi-asserted-by":"publisher","first-page":"790718","DOI":"10.3389\/fmed.2021.790718","volume":"1","author":"M Atif","year":"2022","unstructured":"Atif M, Ahmed W, Nouman Iqbal M, Ahmad N, Ahmad W, Malik I, Al-Worafi YM. Frequency and factors associated with adverse events among multi-drug resistant tuberculosis patients in Pakistan: A retrospective study. Front Med. 2022;1(8):790718.","journal-title":"Front Med"},{"issue":"13","key":"11068_CR30","doi-asserted-by":"publisher","first-page":"883483","DOI":"10.3389\/fphar.2022.883483","volume":"2","author":"A Massud","year":"2022","unstructured":"Massud A, Syed Sulaiman SA, Ahmad N, Shafqat M, Chiau Ming L, Khan AH. Frequency and management of adverse drug reactions among drug-resistant tuberculosis patients: analysis from a prospective study. Front Pharmacol. 2022;2(13):883483.","journal-title":"Front Pharmacol"},{"issue":"1","key":"11068_CR31","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1163\/15718099920522668","volume":"6","author":"D Sprumont","year":"1999","unstructured":"Sprumont D. Legal protection of human research subjects in Europe. Eur J Health Law. 1999;6(1):25\u201343.","journal-title":"Eur J Health Law"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11068-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-11068-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11068-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T12:55:28Z","timestamp":1746622528000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-11068-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,7]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["11068"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-11068-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6156079\/v1","asserted-by":"object"}]},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,7]]},"assertion":[{"value":"4 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The research protocols were submitted for approval by National Bioethics Committee, Pakistan and ethical approval for conducting this study was received (Ref: No.4\u201387\/NBC-491\/20\/48). Protection of patient confidentiality is essential, and the study will follow the principles of the 2018 Declaration of Helsinki.Informed written consent will be obtained from patients or a guardian in the case of minors, as defined by local legal requirements. Those who do not consent to participate in this research will receive treatment as per national guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"This is a study protocol, does not require consent to publish, Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"674"}}